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Objectives. We present clinical data and heart and skeletal
muscle biopsy findings from a series of patients with ultrastruc-
tural accumulations of granulofilamentous material identified as
desmin.
Background. Desmin cardiomyopathy is a poorly understood
disease characterized by abnormal desmin deposits in cardiac and
skeletal muscle.
Methods. Clinical evaluation, endomyocardial and skeletal
muscle biopsy, light and electron microscopy and immunohisto-
chemistry were used to establish the presence of desmin cardio-
myopathy.
Results. Six hundred thirty-one patients with primary cardio-
myopathy underwent endomyocardial biopsy (EMB). Ultrastruc-
tural accumulations of granulofilamentous material were found in
5 of 12 biopsy samples from patients with idiopathic restrictive
cardiomyopathy and demonstrated specific immunoreactivity with
anti-desmin antibodies by immunoelectron microscopy. Immuno-
histochemical findings on light microscopy were nonspecific be-
cause of a diffuse intracellular distribution of desmin. All five
patients had atrioventricular (AV) block and mild or subclinical
myopathy. Granulofilamentous material was present in skeletal
muscle biopsy samples in all five patients, and unlike the heart
biopsy samples, light microscopic immunohistochemical analysis
demonstrated characteristic subsarcolemmal desmin deposits.
Two patients were first-degree relatives (mother and son); another
son with first-degree AV block but without myopathy or cardio-
myopathy demonstrated similar light and ultrastructural findings
in skeletal muscle. Electrophoretic studies demonstrated two
isoforms of desmin—one of normal and another of lower molec-
ular weight—in cardiac and skeletal muscle of the familial cases.
Conclusions. Desmin cardiomyopathy must be considered in
the differential diagnosis of restrictive cardiomyopathy, especially
in patients with AV block and myopathy. Diagnosis depends on
ultrastructural examination of EMB samples or light microscopic
immunohistochemical studies of skeletal muscle biopsy samples.
Familial desminopathy may manifest as subclinical disease and
may be associated with abnormal isoforms of desmin.
(J Am Coll Cardiol 1998;31:645–53)
©1998 by the American College of Cardiology
Disorders of cardiac and skeletal muscle may be associated
with the deposition of excessive amounts of desmin (1), a
polypeptide that is normally aggregated to form intermediate
filaments (2). These filaments derive their name from their
diameter (8 to 10 nm), which is intermediate between that of
the myosin filaments (14 nm) and that of the actin filaments (5
to 7 nm). The intermediate filaments normally form trans-
versely oriented connections linking the Z disks of myofibrils to
those of adjacent myofibrils, the sarcolemma and the nuclear
membranes (1,3–5). Recent studies in transgenic mice (6) suggest
that desmin plays a critical role in cardiomyocyte structure and
function, indicating that desmin filaments constitute an important
component of the cytoskeleton of cardiac myocytes. Pathologic
studies of desmin in human cardiac and neuromuscular disor-
ders have reported markedly increased amounts of this inter-
mediate filament protein (7). In a recent review, Goebel (7)
classified desmin-related disorders into two major groups—the
granulofilamentous type and the cytoplasmic inclusion type—
according to the ultrastructural characteristics.
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In the present report we present clinical, ultrastructural,
immunohistochemical and biochemical findings in six Italian
patients with deposits of desmin-immunoreactive material in
cardiac and skeletal myocytes and a disorder manifested by
restrictive cardiomyopathy (n 5 5), atrioventricular (AV)
block (n 5 6) and variable degrees of skeletal myopathy (n 5
6). We also analyzed previous reports of clinical and pathologic
findings in patients with similar desmin deposits in the heart.
Methods
Patients. From January 1985 to December 1995, 631 pa-
tients affected by primary cardiomyopathies (dilated in 601,
hypertrophic with late dilative-congestive evolution in 18,
restrictive in 12) underwent EMB. Patients with secondary
cardiomyopathy (e.g., amyloidosis, hemochromatosis) were
not included in the series. Five (42%) of the 12 patients with
restrictive cardiomyopathy who underwent EMB, and 1 other
patient who underwent skeletal muscle biopsy only, were found
to be affected by desmin storage cardiomyopathy. In three of
these patients (Patients 1, 2 and 3) the disease was considered
to be sporadic; the other three (Patients 4, 5 and 6) were from
the same family (Fig. 1).
Right ventricular EMB (Caves-Shultz bioptome; three to
four samples for light microscopy and one for electron micros-
copy) and quadriceps femoris biopsies (1 3 1 3 0.5 cm) from
each of the patients were used for histopathologic, immuno-
histochemical and electron microscopic studies. Unfixed, fro-
zen portions of the skeletal muscle biopsy specimens from
patients 2 to 6 were used for enzyme histochemical studies;
frozen samples (heart tissue from Patients 2, 4 and 5 and
skeletal muscle from Patients 2 and 4 to 6) were used for
biochemical studies. Cardiac and skeletal muscle tissue from
10 patients who had undergone heart transplantation for
dilated (n 5 6) and hypertrophic cardiomyopathy (n 5 4) were
used as control samples for immunohistochemical and West-
ern blot studies; our entire series was used as the control for
the ultrastructural study.
Histopathologic study. For histopathologic and immuno-
histochemical studies, the tissues were fixed in buffered 10%
formalin, dehydrated rapidly (8) and embedded in paraffin.
The samples were serially cut to obtain 45 sections, each 5 mm
thick, that were mounted on 15 slides. Sections taken at every
75-mm cutting depth were stained with hematoxylin-eosin and
with the Movat pentachrome method. Single sections were
stained with Mallory trichrome, Congo red and the periodic
acid-Schiff, with and without predigestion by diastase. The
remaining sections were used for the immunohistochemical
studies. Frozen sections were cut at a thickness of 10 mm and
collected on silanized slides. These sections were stained by a
modified Gomori trichrome method, standard methods for the
demonstration of the activity of cytochrome oxidase, reduced
form of nicotinamide-adenine dinucleotide (NADH) dehydro-
genase and acid phosphatase (Bio-Optica staining kits, Bio-
Optica, Milan, Italy) and were also used for some of the
immunohistochemical stains (see later).
Electron microscopic study. For electron microscopy, the
tissues were fixed with Karnovsky’s fixative, postfixed with
1.5% OsO4 in 0.2 mol/liter cacodylate buffer, pH 7.3, dehy-
drated and embedded in Epon-Araldite resin. Ultrathin sec-
tions were stained with lead citrate and uranyl acetate and
examined with a Zeiss 902 electron microscope.
Light microscopic immunohistochemical study. For light
microscopic immunohistochemical studies, sections of
formalin-fixed, paraffin-embedded tissues were reacted with
antibodies against desmin (ZC18, Zymed, prediluted; D8281,
Sigma, 1:20), vimentin (V9, Dako, Denmark, 1:10) and iso-
types of skeletal, cardiac and smooth muscle actin (HHF35,
Enzo Diagnostic, 1:10), using the avidin-biotin complex/
peroxidase method and diaminobenzidine tetrahydrochloride
as chromogen. Frozen sections postfixed with acetone/
chloroform were used to demonstrate dystrophin (NCL-DYS1,
NCL-DYS2 and NCL-DYS3, respectively, directed against the
rod domain, the carboxy terminal and the amino terminal
domain of dystrophin [Novocastra, Newcastle, UK; 1:20]).
Appropriate positive (from 10 heart transplant donors) and
negative (sections incubated without the primary antibody or
with an irrelevant primary antibody) control procedures were
performed in conjunction with all reactions. In addition,
comparisons were made with the staining patterns observed in
similarly processed sections of myocardial biopsy specimens
from 10 patients with dilated cardiomyopathy.
Electron microscopic immunocytochemical study. Elec-
tron microscopic immunocytochemical demonstration of
desmin on ultrathin sections was performed according to
previously standardized methods (9). Immunohistochemical
control procedures for this method were similar to those
described for the light microscopic immunohistochemical re-
actions.
Abbreviations and Acronyms
AV 5 atrioventricular
CK 5 creatine kinase
EMB 5 endomyocardial biopsy
LDH 5 lactate dehydrogenase
NADH 5 nicotinamide adenine dinucleotide, reduced form
Figure 1. Family tree. The disorder appears as inherited, with an
autosomal dominant pattern. I2 corresponds to Patient 4, II1 to
Patient 5 and II2 to Patient 6; II3 died soon after birth; II4 was
unaffected on skeletal muscle biopsy.
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Western blots. One-dimensional electrophoretic studies
were made of samples of cardiac muscle from Patients 2, 4 and
5 and skeletal muscle samples from Patients 2 and 4 to 6, using
a 5% to 15% polyacrylamide linear gradient gel (10). The
tissues were homogenized with 2 volumes of a solution con-
taining 2.3% sodium dodecyl sulfate, 10% glycerol, 5% mer-
captoethanol and 6.25 mmol/liter Tris/HCl buffer, pH 6.8, and
incubated for 5 min at 95°C. Ten microliters of the extract from
each sample were run on polyacrylamide gels; the protein-
loading concentration, determined in accordance with Brad-
ford’s procedure (11), was 30 mg for each lane. After electro-
phoresis, the gels were transferred to nitrocellulose sheets (12)
that were immunostained with mouse monoclonal primary
antibody against desmin and a secondary antibody (goat
anti-mouse) conjugated with alkaline phosphatase.
Statistical analysis. Comparison of frequencies of desmin
accumulation in the groups of patients with restrictive, dilated
and hypertrophic cardiomyopathy was performed by the chi-
square test.
Results
Case reports. All patients in this series were born of
normal pregnancies and deliveries to healthy, nonconsanguin-
eous parents. In all patients, motor and intellectual develop-
ment was normal.
Patient 1. A 17-year old boy was referred in 1989 for
evaluation of restrictive cardiomyopathy (New York Heart
Association functional class II) associated with second-degree
(Mobitz type 2) AV block that required implantation of a
pacemaker. There was no family history of cardiac or neuro-
muscular disease. Chest radiography showed cardiac enlarge-
ment. Echocardiographic study and cardiac catheterization
revealed a restrictive pattern of function. A right ventricular
EMB was performed. Serum levels of lactate dehydrogenase
(LDH) and creatine kinase (CK) were normal. Neurologic
evaluation was normal; however, electromyographic study re-
vealed low amplitude motor unit potentials of short duration
with an early recruitment pattern in the quadriceps femoris
and deltoid muscles. Biopsy of the right quadriceps muscle was
performed. In 1992 he developed complete AV block. The
gluteus medius, tibialis anterior and peroneal muscles were
weak, but the strength of other muscles was normal. The
patient died in June 1993 while awaiting heart transplantation.
A postmortem examination was not performed.
Patient 2. A 21-year old woman was referred in 1992 for
evaluation and management of symptomatic second-degree
(Mobitz type 2) AV block, right bundle branch block and left
anterior hemiblock. The parents, one stepsister and one sister
were clinically normal. A 30-year old paternal uncle had died
suddenly of unknown cause. Chest radiography showed bor-
derline cardiomegaly. Echocardiographic study showed very
mild restrictive ventricular dysfunction and left atrial dilation.
Neurologic examination showed bilateral ptosis of the eyelids
and mild bilateral weakness of the extensor digitorum longus.
Electromyographic study, hearing tests, measurements of se-
rum levels of LDH and CK and evaluation of endocrine
functions gave normal results. Right ventricular EMB and a
quadriceps femoris muscle biopsy were performed. The diag-
nosis of Kearns-Sayre syndrome was excluded by the morpho-
logic findings and by the lack of large-scale deletions or
insertions in the mitochondrial DNA from the muscle biopsy.
A pacemaker was implanted. The patient’s clinical status has
remained unchanged during a 36-month period of follow-up.
Patient 3. A 33-year old woman was referred for evaluation
of restrictive cardiomyopathy (function class III). There was no
family history of heart or neuromuscular disease. At the age of
14 years, in 1975, the patient was found to have elevated
ventricular filling pressures, complete AV block and mild
mitral regurgitation. She was diagnosed as having postmyocar-
ditic cardiomyopathy, and she underwent implantation of a
pacemaker. In 1990, the patient began to develop episodes of
congestive heart failure. Conventional light microscopic study
of a myocardial biopsy, performed at another hospital in 1992,
described nonspecific changes of myocardial hypertrophy. On
referral to our hospital in January 1995, she had dilated atria,
a normal-sized hypokinetic left ventricle, severe pulmonary
hypertension (65 mm Hg) and a small pericardial effusion.
Serum levels of LDH and CK were at the upper limits of
normal. Neurologic examination showed generalized muscle
wasting, with more selected weakness of the distal muscle. The
patient underwent quadriceps femoris muscles biopsy and a
second EMB at our institution. She died 3 months later, while
awaiting heart transplantation. Postmortem examination was
not performed.
Patient 4. A 27-year old man was referred for heart trans-
plantation because of end-stage restrictive cardiomyopathy
and cardiac failure refractory to medical therapy. His mother
(Patient 5) and a 28-year old brother (Patient 6) were also
referred for evaluation. A 24-year old sister was also evaluated
clinically and underwent skeletal muscle biopsy. Another
brother had died suddenly 10 h after birth. At age 8 the patient
had a syncopal episode and was found to have right bundle
branch block. At age 22, he underwent implantation of a
pacemaker for complete AV block. At age 24 he developed
cardiac failure with a low output syndrome. Cardiac catheter-
ization and echocardiographic study showed a normal-sized
left ventricle with a restrictive pattern of dysfunction. Neuro-
logic examination, including electromyography and repetitive
nerve stimulation tests, disclosed no abnormalities. Serum
levels of LDH and CK were normal. The patient had EMB and
biopsy of the quadriceps femoris muscle. He underwent heart
transplantation.
Patient 5. The 55-year old mother of Patients 4 and 6
developed palpitations and cardiac enlargement at age 23. At
age 35, she had a pacemaker implanted because of complete
AV block and left posterior hemiblock. Cardiac failure first
developed at age 48. At age 54 she was referred for evaluation
of continuing episodes of cardiac failure. An echocardiogram
showed right ventricular dilation and normal left ventricular
motion. Cardiac catheterization disclosed elevated filling pres-
sures and a pattern of restrictive dysfunction. Neurologic
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examination, including electromyography and repetitive nerve
stimulation tests, disclosed no abnormalities. Serum levels of
LDH and CK were normal. The patient had EMB and
quadriceps femoris muscle biopsy. She underwent heart trans-
plantation.
Patient 6. This 28-year old man, son of Patient 5 and
brother of Patient 4, was asymptomatic and clinically normal
but had first degree AV block. Neurologic examination was
normal. Echocardiographic and scintigraphic studies gave nor-
mal results. Right ventricular EMB, performed at another
institution, was reported as showing myocyte hypertrophy and
interstitial fibrosis (no electron microscopic or immunohisto-
chemical study was made). Needle biopsy of the quadriceps
femoris muscle was performed at our institution.
Histologic observations. Heart. Histologic study of the
EMB specimens (Fig. 2a) from five (Patients 1 to 5) of the six
patients revealed only variable degrees of myocyte hypertrophy
and fine, diffuse interstitial fibrosis (minimal in Patient 2,
moderate in Patients 1, 3, 4 and 5). Endocardial thickening,
myocardial inflammation and vascular abnormalities were not
present. Minimal disarray of the myocytes was noted in all
patients. Nuclei with bizarre shapes were present in some of
the myocytes from Patients 4 and 5. The myofibrils were focally
lysed in some cells from Patients 1, 3, 4 and 5. However, no
changes suggestive of any storage disease were observed in any
of the specimens. Amyloid deposits and accumulations of
abnormal amounts of glycogen were not detected.
Skeletal muscle. Examination of the quadriceps femoris
muscle showed mild fibrosis in Patients 1, 3, 4 and 5 (Fig. 2b).
Frozen sections (Patients 2 to 6) stained by the Gomori
trichrome method showed peripherally located sarcoplasmic
masses that stained deep green. Ragged red fibers were not
found. Areas devoid of NADH diaphorase activity, such as
those found in central core disease, were not detected. Stain
for acid phosphatase showed mildly increased reactivity in
Patients 2 and 5, mostly in subsarcolemmal areas.
Ultrastructural observations. Heart. Ultrastructural ex-
amination of the five EMB specimens showed multiple depos-
its of granulofilamentous and electron-dense amorphous ma-
terial in perinuclear, subsarcolemmal and intermyofibrillar
areas (Fig. 3). These deposits were not enclosed by limiting
membranes. In Patients 2 and 4 they also were distributed in
register with the Z bands, with which they often appeared to be
continuous. The extent to which the deposits were present
varied among different cardiac myocytes and among the five
patients (mild in Patient 2, moderate in Patients 4 and 5, severe
in Patients 1 and 3). The mitochondria showed nonspecific
abnormalities. None of the remaining control biopsies investi-
gated at the electron microscopy level showed similar ultra-
structural features.
Skeletal muscle. In all six patients the skeletal muscle cells
contained deposits that were morphologically identical to
those found in the cardiac muscle cells (Fig. 4). They were
almost exclusively subsarcolemmal, rarely extending between
the myofibrils. Endothelial cells, fibroblasts and nerves did not
contain similar deposits. The deposits were most abundant in
the biopsy specimens from Patients 1 and 3 and progressively
less extensive in Patients 4, 5, 2 and 6. The skeletal muscle
mitochondria were morphologically normal in all six patients.
The skeletal muscle biopsy of the sister of Patients 4 and 6 was
normal.
Light microscopic immunohistochemical observations.
Heart. Staining for desmin (Fig. 5a–c) showed a pattern of
immunoreactivity that corresponded to the distribution of the
deposits observed by transmission electron microscopy. In
many cells (.50%) the pattern of reactivity was irregular but
was associated with the pattern of staining at the levels of the
Z bands, as usually seen in idiopathic dilated cardiomyopathy
(Fig. 5b).
Skeletal muscle. Study of skeletal muscle confirmed the
presence of desmin-immunoreactive subsarcolemmal deposits
(Fig. 5d). As in cardiac muscle, the distribution of the reactivity
for desmin matched that of the material observed by transmis-
sion electron microscopy. Immunostaining for dystrophin gave
normal results in all cardiac and skeletal muscle biopsy speci-
mens. The skeletal muscle samples of our 10 control cases and
Figure 2. Histologic sections of heart and skeletal muscle. a, Myocar-
dium from Patient 5, showing mild interstitial fibrosis and focal
myocyte hypertrophy, with prominent nuclei and minimal disarray. b,
Skeletal muscle from Patient 4. Variations in fiber size are evident.
Hematoxylin-eosin 3250, reduced by 42%.
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of the sister of Patients 4 and 6 did not show abnormal desmin
immunoreactivity.
Ultrastructural immunocytochemical observations. Ultra-
structural immunocytochemical study of cardiac (Fig. 6a) and
skeletal (Fig. 6b) muscle sections showed a specific reactivity of
anti-desmin antibody with the material described earlier.
Electrophoretic study of desmin. One-dimensional gel
electrophoresis of skeletal and cardiac muscle from Patient 2
showed a single band of desmin reactivity (identified by specific
immunostaining) of 55 kilodaltons (kDa). This band had the
same molecular weight but was thicker than those obtained
from the skeletal muscle and from the cardiac muscle of
normal control subjects and patients with other types of
cardiomyopathies. Two bands with desmin reactivity were
found in all samples of skeletal muscle and heart from Patients
4, 5 and 6, who belong to the same family. One of the bands
had a normal molecular weight (55 kDa), whereas the second
band corresponded to a smaller isoform of desmin, with
53-kDa molecular weight. These observations are shown in
Figure 7.
Statistical analysis. Cases of desmin accumulation were
significantly higher in restrictive than in other cardiomyopathy
types (chi-square 260.81, 2 degrees of freedom, p 5 0.000).
Discussion
Characteristics of desmin cardiomyopathy. The present
study describes the finding of granulofilamentous, desmin-
immunoreactive material in a series of patients with restrictive
cardiomyopathy, disturbances of AV conduction and skeletal
myopathy of variable onset and severity. These pathologic
findings are characteristic of desmin-related disorders, or
desmin cardiomyopathy.
Desmin cardiomyopathy, unlike other forms of cardiomy-
opathy, requires ultrastructural study for diagnosis. By light
microscopy, the excess of desmin microfilaments is found
throughout the sarcoplasm. Therefore, the immunohistochem-
ical findings are not sufficiently different from the abnormal
staining patterns seen in dilated and hypertrophic cardiomy-
opathy (13–15). However, ultrastructural observations in
desmin cardiomyopathy are distinct from those of other forms
of cardiomyopathy and consist of striking granulofilamentous
deposits that we did not identify in any cases of dilated
cardiomyopathy. The clinical findings of desminopathy are
likewise distinct, supporting the concept that desmin cardio-
myopathy is a separate clinicopathologic entity. Restrictive
hemodynamic variables and AV block, characteristic of desmin
cardiomyopathy, are not consistent features of hypertrophic
Figure 3. Transmission electron micrographs of cardiac muscle. a,
Myocyte from Patient 4 contains multiple deposits of granulofilamen-
tous material in intermyofibrillar areas. b, Longitudinal sections of
myocyte from Patient 5, showing localization of deposits of granulo-
filamentous material at the levels of the Z bands. c, Higher magnifi-
cation view of myocyte from Patient 5, showing aggregates of granu-
lofilamentous material and intermyofibrillar bundles of intermediate
filaments, some of which are attached to Z bands. a (37,000), b
(312,000), c (313,000), all reduced by 41%.
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cardiomyopathy and are not found in dilated cardiomyopathy.
We hypothesize that the failure of desmin to aggregate into
intermediate filaments, as indicated by the observed masses of
granulofilamentous material, is responsible for the structural
disorganization of the cytoskeleton of the myocytes, which in
turn leads to impairment of both relaxation and contraction
and results in the abnormal diastolic and systolic function that
characterizes restrictive cardiomyopathy.
Although the light microscopic features of cardiac biopsy
specimens in patients with desmin cardiomyopathy are non-
specific, our data suggest that immunohistochemical distribu-
tion of desmin filaments in skeletal muscle biopsy samples is
characteristic of the disease. We demonstrated typical desmin-
immunoreactive deposits localized in the subsarcolemmal
areas with a crescentic, semilunar distribution. Because diag-
nostic findings were present in all six patients, biopsy of
skeletal muscle may be helpful, even in the absence of clinical
myopathy.
Review of published reports of desmin abnormalities in
cardiomyopathy. In a review of published reports, we identi-
fied 26 patients with desmin cardiomyopathy on the basis of
ultrastructural presence of granulofilamentous material depos-
its in cardiac or skeletal muscle myocytes, or both (16–40). In
a few cases, this material was identified as desmin by direct
immunocytochemical characterization (38–40); in the others,
either desmin-immunoreactive deposits were observed on light
microscopy immunohistochemical study of the same bioptic
samples (21,22,24,27–37) or abnormal desmin-immunoreactive
bands were demonstrated on Western blot of cardiac or
skeletal muscle tissue (18,22,29,32). In a limited number of
cases reported before the development of immunohistochem-
Figure 5. Light micrographs of
immunohistochemically stained
(avidin-biotin complex/peroxidase;
nuclei were counterstained with
hematoxylin) preparations; 3250,
reduced by 40%. a, Normal pat-
tern of distribution of desmin in
pretransplant biopsy of donor
heart. The reaction is localized
along the Z bands and the inter-
calated disks. b, In cardiac myo-
cytes of a patient with dilated
cardiomyopathy, focal accumula-
tions of desmin are present, but
their morphology is not sufficiently
distinctive to differentiate them
from those shown in Figure 4c. c,
Myocardium from Patient 2 shows
marked increase in immunoreac-
tivity for desmin, which is localized
in irregular masses. d, Subsar-
colemmal deposits of desmin-
immunoreactive material are pres-
ent in skeletal muscle fibers from
Patient 4. Compare with Figure 4.
Figure 4. Transmission electron micrographs of quadriceps femoris
muscle from Patient 4. Low (a) and high (b) power views of muscle
fiber showing large deposits of granulofilamentous material in subsar-
colemmal areas. a: 37,000, b: 312,000, both reduced by 36%.
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istry, unequivocal granulofilamentous deposits were not fur-
ther characterized as desmin (16,25). Of these cases, restrictive
cardiomyopathy was present in nine (definite in six, presumed
from the clinical description in three) (16,19,21,25,26,29,32–
34,40), hypertrophic cardiomyopathy in two (17,19,21), dilated
cardiomyopathy in one (26), cardiomyopathy not further spec-
ified in eight (19,28,31,36–39), not otherwise specified conges-
tive heart failure with pulmonary hypertension in two (22,24)
and only AV conduction disturbances in four (17,35). Al-
though most of the 26 patients described had some form of AV
block, the structure of the AV conduction system was studied
in only one patient who had undergone transplantation (28), in
whom the desmin deposits formed well defined intermediate
filaments and involved the bundle of His and its branches
(especially the left) to a much greater extent than the atrial and
ventricular myocardium. Because the conduction pathways
were not interrupted, the AV block was attributed to the
deposition of desmin in the conduction cells.
Although most patients reported in the published reports
had clinically overt myopathy, the age at onset, pattern of
involvement of muscle groups and severity were all variable. In
our patients, only one of six patients had early symptoms of
muscular impairment, and these were mild. In three others,
skeletal myopathy became evident only very late in the disease.
Diagnostic criteria. The prevalent restrictive pattern in
affected hearts described in the published reports, as well as in
our series, suggests that the combination of restrictive cardio-
myopathy and disturbances of the AV conduction should raise
the possibility of a desmin-related disorder. The diagnosis
needs confirmation by immunohistochemical studies for
desmin and electron microscopic studies. Ultrastructural anal-
ysis constitutes the only means for identifying this type of
disorder on EMB samples. If, for clinical reasons, a skeletal
muscle biopsy is available and shows features diagnostic for
desminopathy in a patient who also has restrictive cardiomy-
opathy or AV conduction disturbance, an EMB is not neces-
sary for diagnosis.
Biochemical considerations. In the present study, we dem-
onstrated by immunogold labeling that the abnormal filaments
seen ultrastructurally are composed of desmin myofilaments.
By one-dimensional gel electrophoresis, we demonstrated an
increase in desmin band thickness in one patient with sporadic
disease, a finding similar to that reported by Rappaport et al.
(18), Bertini et al. (30), Sabatelli et al. (32), Edstrom et al. (22)
and Baeta et al. (39). To our knowledge, we demonstrated for
the first time by one-dimensional gel electrophoresis, the
coexistence of two isoforms of desmin—one of normal molec-
Figure 7. Nitrocellulose sheet immunostained with mouse monoclonal
antibody against desmin. The protein loading concentration was 30 g
for each lane. MW 5 molecular weight. Lane 1, normal control
(normal donor heart); lane 2, heart from Patient 2; lane 3, skeletal
muscle from Patient 2; lane 4, heart from Patient 4; lane 5, skeletal
muscle from Patient 4; lane 6, heart from Patient 5; lane 7, skeletal
muscle from Patient 5; lane 8, skeletal muscle from Patient 6; lanes 9
and 10, hearts from two patients with dilated cardiomyopathy.
Figure 6. Transmission electron micro-
graph of sections stained to show the
ultrastructural localization (gold-labeled
antibody method) of desmin. Myocardium
(a) and skeletal muscle (b) from Patient 5
show deposits of granulofilamentous ma-
terial that are intensely labeled (desmin)
by gold particles. 314,000, reduced by
40%.
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ular weight, compared with that of the control subjects and in
accordance with previous biochemical characterization, and
the second of 53-kDa molecular weight. This isoform was
demonstrated only in the three related patients with familial
desmin cardiomyopathy. Phosphorylated acidic isovariants of
desmin have been described in patients with desmin cardiomy-
opathy (18,30,32), an interesting finding given that the ability
of desmin to become organized into intermediate filaments is
inversely related to the degree to which this protein is phos-
phorylated (41,42). However, by one-dimensional gel electro-
phoresis these isovariants resulted in a single band of normal
molecular weight and increased thickness compared with that
in control subjects (18,30,32). Although the presence of abnor-
mal isoforms of desmin suggests a genetic defect, none has
been detected by sequencing of desmin cDNA or genetic
linkage studies in three families (43). It is possible that the
genetic defect lies in a second protein that interacts with the
transcription or translation of the desmin gene or with the
protein itself (43). The significance of our finding of an
abnormal isoform of desmin has yet to be clarified.
Conclusions. Desmin cardiomyopathy is characterized by
restrictive cardiomyopathy, AV conduction disturbances and
myopathy that is histologically manifest early but clinically only
later in the course of disease. A desminopathy should be
suspected in patients presenting with restrictive cardiomyopa-
thy, especially when combined with AV block. The diagnosis is
confirmed by accumulations of desmin-immunoreactive mate-
rial in cardiac muscle, which must be confirmed ultrastructur-
ally, and in skeletal muscle, which may be seen on light
microscopic immunohistochemical analysis. Optimally, immu-
nohistochemical and ultrastructural studies of heart and skel-
etal muscle are both necessary because they constitute the
best means of distinguishing the deposits of desmin-
immunoreactive material from those that occur as nonspecific
cytoskeletal abnormalities secondary to cardiomyopathy asso-
ciated with cardiac dilation or hypertrophy.
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